Emerging Markets in Life Sciences Syrposium:

The Power of Partnershrps

Thursday, July 24,2OL4L2:OOPM - 4:00PM EST

620 Eighth Avenue #33

Presented By

Center for

- Healthcare[,rnnovaron

The Emerging Markets in Life Sciences Symposium l: The Power ofPartnerships is one of the world's leading annual events focusedspecifically on emerging markets of the global life science industry,including IATAM, China, lndia, Africa, and Eastern Europe and Russia.The symposium is an interactive, collaborative setting for the world'sleading life science and healthcare executives, entrepreneurs, policy-makers, researchers, scientists, technologists, academics, and serviceproviders to exchange best practices and discuss the opportunities andchallenges of emerging life science markets around the globe' Thesymposium also explores how partnerships are key to achievingsuccess in emerging pharmaceutica! markets. Participants will gainvaluable contacts, connections, knowledge, information, and insights.

Dear Symposium Attendees,

On behalf of the Center for Healthcare lnnovation (CHl), we welcome you to the2nd annual Emerging Markets in Life Sciences Symposium l: The Power ofPartnerships. lt is a privilege to welcome back those who participated in lastyear's symposium, as well as greet newcomers to our collaborative discussion.

Our goal for today is to provide an intimate, selective, and collaborative settingfor leading life science and healthcare executives and thought-leaders todiscuss the intersection of the life science industry and emerging markets.From issues such as the power of partnerships, a rapidly-growing global middle-class, increased consumer demand, the availability of skilled human capital,political and governmental structures, the protection of intellectual property and

compliance within the global regulatory framework, and new and attractiveregions for R&D and clinical trials, we hope today's symposium provides acollaborative setting to discuss the challenges, opportunities, and best practices

surrounding the life science industry in emerging markets.

We would like to thank all of today's supporters, including our host, SeyfarthShaw, our Co-promotion partners, and all our distinguished moderators andpanelists. Finally, we would like to thank you all for joining today's discussion.We wish you an informative and productive afternoon, and hope you enjoytoday's discussion surrounding emerging markets in the life sciences.

Kindest Regards,Symposium Planning CommitteeCenter for Healthcare lnnovation

PRESEITTED BYCenter for Healthcare Innovation (CHI)CHI is a 501(c)(3), non-profit research center committed to excellenceand innovation in the global life sciences industries, primarily thebiotech, medical device, and pharmaceutical sectors. We aim to bethe world's #1 source of rigorous, objective thought-leadership andinnovative solutions for the international life science ecosystem.

20 14Supporters

F{$ST

SEYFARTHArroR''r Eys'SFf,W;

Breacith. Depiir. Results.

PR.O}{ OTIO N PART}TER*S

p ruvu lnnrs & scrENcECenter for Bioethics; Life, Health & Environment

I NYCNew York City Economic Development Corporation

ffirifl{rx"$tM*

Center for

- HealthcareOr rnnovaron

Ob:ective Research. [ffect]ve Solutions.

lailn

S+"Jr"A- k*. tl'{ qyiu kl ?i'*nt

Registration, Lunch, & Networki.g l2:00- l2:55

Opening Remarks l2:55- l:00. Mr.Joff Masukawa, SpecialAdvisor; Center for Healthcare lnnovation; Vice President and Global

Head, Government Relations and Public Affairs, Shire. Mr. Brent Schneider, Strategic Development Lead, Center for Healthcare lnnovation

Strategy & New Market Entry Panel Discussion l:00- l:50. Mr. Raymond Arroyo, Board Member; National Hispanic MedicalAssociation; Secretary & Chairman .

:S':::*:.?:::.:',?,::x,':';11',:tH!l1T,T::l--t:::::*g?,*:'ffi$"ffiY^1'ff^x:,fr'*"{u D* Pramod Gaur, Vice Chair; AmericanTelemedicineAssociation Wth^q?n#.['#;,}{ . F1* Rick Henrig, CIO PartnenTatum; Executive Director, Health lT, Bristol-Myer\rSquibb (forme}) "-i . Mr. Rick Henrig, CIO Partnerfatum; Executive Director; Health lI BrlstoljMye\Squibb (fon

**\r. Mr:Anthony Romagnole, Managing Partner; CVt Consulting; Senior Director, Pfir\ (former);-\ Managing Partner,CVl Consulting - Yr'&.1 ofhrxrza-G;tntr\Brt llqrtarJ,-f BS r^ [^7*\,*-,

. Dn Bratislav Stankovic, ChaiG Strategic Planning and Transition Committee, PublicI ntellectual Property Advisors vru ErLsVN E{lrr*Ls

hhr{ tto./H-\ l^rq rlwt{-t,

"ol gnf ' z !"Ot_U"atr^l*s;

Reseorch & DeveloPment and Alliances Panel D iscu ssion "foo:/5ii'"

. Ma Esteban "Steve" Ferrer, Partner; Sey'arth Shaw (Moderator)

. DnJohn Doyle, SeniorVice President and Managing Directori Global MarketAccess &Cgmmgrgi_alization.-Qujntiles;Assistant Professo[ Columbia University :

. Ml:ft.Xtititiit'ul6t, bl5biivice President,Alliance Management, Covance 6*J,,*.,ol, otqriz{ ^eass

. Mn Alan Polonsky, Global Directo[ Sourcing,Thermo Fisher Scientific

. Mr. Deva Puranam, Global Director of Quality, Regulatory, Compliance, and New ProductDevelopment,Thermo llbgr Scientific *a caururt,.o bivl,os s" ),*.^tw""{

Morketing & Business DeveloPment Panel Discussion 3:00-3:50. Mr, Laurence Birch, Chairman & Chief Executive Officer, Datatrak (Moderator). Dr. OmarAlvarez-Pousa, Director; BusinessTechnology,Zoetls (formerly PfizerAnimal Health);

Adiunct Professori NYU. Mr. Craig Delarge, Global Leaden Multichannel Marketing Strategy & lnnovation, Merck (former). Mr,Angel lriz4rry, Senigr Qlrggtog Supportive- Care; U.S. Oncology Marketing, Easai. ryrrylE*zffiffilrtg,*6#e';g#i'S;fiAh3i-y.fi{81fih" ,.as or$l i' 6nd* 1*$.^n ** $",yafl. iffJeremieTrochu, Head of Global Marketlng & Strategy, Catalent Pharma Sotutions. Mr.AlanVanderborght, Founder and Principal,Torreya-EM; CEq Lucas Pharma

Closing Remarks 3:50-4:00. Mn Dennis Urbaniak, Chairman of Executive Council, Center for Healthcare lnnovation; Managing

Directo[ Accenture

Registration, Lunch, & Networking l2:00- l2:55

Opening Remarks I2:55- !:00. Mr.foff Masukawa, SpecialAdvisor; Center for Healthcare lnnovation; Vice President and Global

Head, Government Relations and Public Affairs, Shire. Mr. Brent Schneider, Strategic Development Lead, Center for Healthcare lnnovation

Strate gy & New Morket Entry Pane! Discussion I :00- I :50Mr. Raymond Arroyo, Board Member, National Hispanic MedicalAssociation;Secretary & ChairmanElect of the Board of Directors, U.S. Hispanic Chamber of Commerce (Moderator)Dr. Pramod Gaur, Vice Chair, American Telemedicine AssociationMr. Rick Herwig, CIO Partner,Tatum; Executive Director, Health lT, Bristol-Myers Squibb (former)Mr.Anthony Romagnole, Managing Partner, CVI Consulting;Senior Directori Pfizer (former);Managing Partneri CVI ConsultingDr. Bratislav Stankovic, Chair, Strategic Planning and Transition Commitree, Public lnterestI ntel lectual Property Advisors

Reseorch & Development and Allionces Panel Discussion 2:00-2:50

a

a

Mr. Esteban "Steve" Ferrer, Partne6 Seyfarth Shaw (Moderator)Mr.fos6 Oct6vio Costa Filho, GCTO PMO / Clinical Development for Emerging Markets, MerckDaJohn Doyle, SeniorVice President and Managing Directori Global MarketAccess &Com me rcial ization, Qu i nti I es; Ass istant Professo r, Co I u m bia U n iversityMs. Katie Margules, Global Vice President,Alliance Management, CovanceDr. Luis Rios-Nogales, Head, Global Development Delivery,Takeda Vaccines

Morketing & Business Development Panel Discussion 3:00-3:50. Mr. Laurence Birch, Chairman & Chief Executive Officer, Datatrak (Moderator). Dr. Branimir Brankov, Head of Emerging Markets Business Development, Merck. Mr. Craig DeLarge, Global Leader; Multichannel Marketing Strategy & lnnovation, Merck (former). Mr.Angel lrizarry, Senior Directo6 Supportive Care; U.S. Oncology Marketing, Easai. Mr.feremieTrochu, Head of Global Marketing & Strategy, Catalent Pharma Solutions. Mr. Alan Vanderborght, Founder and Principal,Torreya-EM; CEq Lucas Pharma

Closing Remarks 3:50-4:00. Mr. Dennis Urbaniak, Chairman of Executive Council, Center for Healthcare lnnovation; Managing

Directoti Accenture

AccentureAllscriptsAmerican Telemedici ne AssociationBaxter lnternationalBDBiogen ldecCatalent Pharma SolutionsCenter for Healthcare !nnovationColumbia Business SchoolColumbia UniversityCovanceCVI ConsultingDatatrakEisai!nformation Management Network (lMN)LatinTRENDSLucas PharmaMerckNational Hispanic Life Sciences SocietyNational Hispanic Medical AssociationNew York City Economic Development CorporationNovartisNYUNYU Center for BioethicsPfizerPrinceton UniversityPublic Interest lntellectual Property AdvisorsQuintilesSeyfarth ShawShireTakeda VaccinesTatumThe Feinstein lnstitute of North Shore-LlJ HealthSystemTorreya-Emerg ing MarketsU.S. Hispanic Chamber of CommerceWomen !n Healthcare & Life Sciences

I Committed to Excellence $'!l V 2OlS lYlNXEn r[V f nr^so,snrcu,suro Vg+rr PEERAWARDSd.I9

lnnovative Law Firm of the YearReceived the top two awards for excellencein innovation and t{hnology used by lawfims prsmted bythe lnttrnational Legal

Technology Assciation (ILTA).

lnnovation LeaderR<ognized as the top-ranking

fim to r innovation to deliErlegal sflice aligned with client

reeds based m corporate counselfedback f rom the world's larg6t

companis.

Client Service Elite HonorsFor the third conscutive year, S€yfarth was

named to BTI Consulting's Client Seruice

30 list, which represents the "cream of tlecrop" of law firms on client service.

@se*ACC Value Champion

RKognized as an ACC Val€Champion fs our innovativecollaboratim with a clbnt lo

manage its outsurcing ofcontracts.

h*j@>Most Innovative

A\Er(bd to Lt#ging PanntrStephs P€r for h6 instumentalrde in the creation and evolutonof the fim's client *Mce model,

5 eyfarthlean.

Fi*ancral IImes{,rS /nnoyafive Lavuyers Report

tinancial Times US LawFirm lnnovator

Seyfarth earned a spot among the FfUslnnovative Lawyers 2013 index of tlE m6t

innovative firms, including top-rankinghonors in the Business of Law.

lnnovAction AwardsRecognized for "outstanding

innovation in the delivery of legal

-rvics" by the College of LawPractice Management (COLPM).

p r.rvu lenrs & scrENcECenter for Bioethics: Life, Health & Environment

NYC..New York City Economic Development Corporation

ff$im"lxtMJa

lANNIRTilII$

Special thanks to past sponsors and supportersof previous events, conferences, and symposia

ffi Microsoft

Katten ,.r..tt1fOIDnrerRAK

I BDO Pharggg$icar lTiflderII'TERHTLL EIATASTTE'X Smart. Simpte, Serure,

Center for- Healthcare

[. lnnovation

.@'''"'_

The World's Leading Think Tank for the Global Life Science Ecosystem

.. - ":*''.=-:

Obiecrve Research. Efective Soiutic:s

Healthcare

WhoWeAre

An organization comprised of accomplished and talented individuals from a rich array of backgrounds, cultures, and experiences:

GLOBAL COUNC'Lo Dr. Bavaguthu Raghuram Shetty, Founder, Managing Director & CEO, NMC Group. Dr. Bandi Parthasaradhi Reddy, Founder, Chairman, CEO, & Managing Director, Hetero Groupo Dr. Anita Goel, Founder, Chairman, & Scientific Director, Nanobiosym; Chairman & CEO, Nanobiosym Diagnostics

BOARD OF D'RECTORSo Mr. Michel J. Feldman (Chairman), Partner, Sey'arth Shaw; Founding Board Member, Watson Pharmaceuticalsr Dr. Nelson L. Levy (Vice Chairman), Chairman & CEO, CoreTechs Corporationo Dr. Samir Bhattacharyya, World Wide Director of Market Access, Depuy Mitek, a Johnson & Johnson Companyo Dr. fames J. Gillespie, Chief Executive Offlcer & Co-Founder, Center for Healthcare lnnovationo Mr. Sanjay Kadaveru, Co-Founder, Center for Healthcare lnnovationo Dr. Linda McAllister, Chief Medical Officer & Vice President of R&D, PharmaJet. Dr. Andrea Small-Howard, President, lnternational Biotechnology Solutions

EXECUTIYE COUNC'Io Mr. Dennis Urbaniak (Chairman), Managing Director, Accentureo Dr. Laurent Audoly (Vice Chairman), Senior Vice President, Research & Development, Fabre Laboratorieso Ms. foanna Brougher, Senior Council, Vaccinex. Mr. Lewis Feldberg, Chief Executive Officer, Esteve USA (former)o Dr. Albert Jaramillo, Vice President, Human Resources, Global R&D, Pfizer (retired)o Mr. Michael Ndmoli, Vice President Life Sciences, Solution Management, SAP Labs (former)r Ms. f ulie Sawyer-Montgomery, Vice President, Global Medication Management Systems & Business Insights, Hospirar Mr. Richard Smith, Managing Director, Life Sciences & Specialty Services, FedEx Expresso Dr. Eckhard von Keutz, Senior Vice Presideng Head Global Early Development, Bayer HealthCare

STRATEGY GROUPo Mr. James Jordan (Chairman), Distinguished Service Professor in Healthcare & Biotechnology Managemeng Carnegie Mellon Universityo Mr. Mark Kwatia (Vice Chairman), Diagnostics Assay Design, Abbott Laboratorieso Dr. G. Randall Green, Founder, Secant Therapeuticso Dr. Marco Quarta, Director, lnstitute for Bioengineering in Stem Cell & Regenerative Medicine, Stanford Universityo Dr. Kate Rosenbluth, Biodesign lnnovation Fellow, Stanford Universityo Dr. James Su, Senior Research Engineer, Abbott Vascular

SPECIAL ADY'SORSo Mr. Mark Hattas, Founder, Former CEO, & Chairman, Genecao Mr. Joff Masukawa, Vice President and Global Head, Government Relations and Public Affairse Dr. Stuart Rich, Professor of Medicine, University of Chicago

C.^,':;;;,t. ii-. I,S;- ia-:;e r *', :-",2: -:; ,'i':. info@chisite.orq chisite.oro ffi fiE f,I *-

Upcoming EventsUnintended Consequences of Healthcare & Life Science LegislationA symposium for leading life science and healthcare executives, entrepreneurs, policymakers, researchers, scientists,

technologists, academics, and service providers to collaborate in a non-paftisan forum for discussing the unintendedconsequences of healthcare and life science legislation in the U.S. and around the worlfoWednesday, October I5, 2014Washington, D.C., USAch isite.org/events/Legislation

lnnovative Partnerships in Healthcare Executive RoundtableAn invitation-only, executive roundtable discussion for senior healthcare and life science executives to discuss

partnerships, collaboration, and innovation among the key stakeholders of the 2lst Century healthcare syste1,Thursday, October, 6, 20 I 4

ch isite.org/events/i n novative Partn e rsh i ps

Emerging Markets in Life Sciences Symposium ll:The Role of RelationshipsOne of the world's leading annual events focused specifically on emerging markets of the global life science industry,including LATAM, China, lndia, Africa, and Eastern Europe and Russia. The symposium is an interactive, collaborativesetting for the world's leading life science and healthcare executives to exchange best practices and discuss theopportunities and challenges of emerging life science markets around the globe. The symposium explores howrelationships are key to achieving success in emerging pharmaceutical markets. Participants will gain valuable

contacts, connections, knowledge, information, and insights.Thursday, October 23, 20 I 4San Francisco, CA, USAch isite.org/events/em ergi ngMarketsRelationsh i ps

Diversity, lnclusion, & Life Sciences SymposiumAn interactive and collaborative symposium for life sciences and healthcare executives to discuss best practices as

well as challenges and opportunities at the crucial interface of diversity, inclusion, and the life sciences industry.Participants will gain valuable contacts, connections, knowledge, information, and insights $Wednesday, June I0, 2015Chicago, lL USAI ifesciencesd iversity.org

Priscilla EspinosaVisiting:32nd Floor

Seyfarth Shaw LLPThe New York Times Building

07-24-2014

i$+F